ArticleJACC. Advances2022
Augmented Intelligence to Identify Patients With Advanced Heart Failure in an Integrated Health System.
Article in JACC. Advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 17 citations in OpenAlex.
- Artificial Intelligence for Cardiovascular Care in Action: From Learning to Implementation in Health Systems.JACC. Advances · 2025Review
- Artificial intelligence in heart failure - a comprehensive literature review.Cardiology journal · 2025Review
- AI and Heart Failure: Present State and Future With Multimodal Large Language Models.JACC. Advances · 2024Article
- Population Health and Artificial Intelligence.JACC. Advances · 2024Article
- Northwestern University resource and education development initiatives to advance collaborative artificial intelligence across the learning health system.Learning health systems · 2024Article
- Enhancing heart failure treatment decisions: interpretable machine learning models for advanced therapy eligibility prediction using EHR data.BMC medical informatics and decision making · 2024Article
- The Emerging Role of Artificial Intelligence in Valvular Heart Disease.Heart failure clinics · 2023Review
- Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network.PloS one · 2023Article
- Diagnostic AI and Cardiac Diseases.Diagnostics (Basel, Switzerland) · 2022Review
- Can Machines Find the Sweet Spot in End-Stage Heart Failure?JACC. Advances · 2022Article
Corrections and comments
- Commented on by
Authors and funding
17 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundTimely referral for specialist evaluation in patients with advanced heart failure (HF) is a Class 1 recommendation. However, the transition from stage C HF to advanced or stage D HF often goes undetected in routine care, resulting in delayed referral and higher mortality rates.
objectivesThe authors sought to develop an augmented intelligence-enabled workflow using machine learning to identify patients with stage D HF and streamline referral.
methodsWe extracted data on HF patients with encounters from January 1, 2007, to November 30, 2020, from a HF registry within a regional, integrated health system. We created an ensemble machine learning model to predict stage C or stage D HF and integrated the results within the electronic health record.
resultsIn a retrospective data set of 14,846 patients, the model had a good positive predictive value (60%) and low sensitivity (25%) for identifying stage D HF in a 100-person, physician-reviewed, holdout test set. During prospective implementation of the workflow from April 1, 2021, to February 15, 2022, 416 patients were reviewed by a clinical coordinator, with agreement between the model and the coordinator in 50.3% of stage D predictions. Twenty-four patients have been scheduled for evaluation in a HF clinic, 4 patients started an evaluation for advanced therapies, and 1 patient received a left ventricular assist device.
conclusionsAn augmented intelligence-enabled workflow was integrated into clinical operations to identify patients with advanced HF. Endeavors such as this require a multidisciplinary team with experience in design thinking, informatics, quality improvement, operations, and health information technology, as well as dedicated resources to monitor and improve performance over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.